SAMBA HIV Semiquantitative Test, a New Point-of-Care Viral-Load-Monitoring Assay for Resource-Limited Settings
Allyson V. Ritchie(University of Cambridge), Helen Lee(University of Cambridge), Hrishikesh Joshi(University of Cambridge), Neha Goel(University of Cambridge), Daniel Edemaga(Médecins Sans Frontières), Annemiek de Ruiter(ViiV Healthcare (Spain)), Elisabeth Szumilin, Jean‐Pierre Allain(University of Cambridge), Isabelle Jendrulek(Guy's and St Thomas' NHS Foundation Trust), Ines Ushiro‐Lumb(NHS Blood and Transplant), Megan McGuire(Médecins Sans Frontières), Pia Sharma(University of Cambridge)
Cited by 94
Related Papers
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
|Infectious Diseases and Therapy|2018|197